Wuppertal, Germany

Hans-Georg Dellweg

USPTO Granted Patents = 8 

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 1992-1999

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Hans-Georg Dellweg: Advancements in Biocatalysis and Medicinal Chemistry

Introduction: Hans-Georg Dellweg is a prominent inventor based in Wuppertal, Germany, recognized for his significant contributions to the field of biocatalysis and medicinal chemistry. With a portfolio of eight patents, Dellweg’s innovations have made substantial impacts on pharmaceutical processes, particularly in enzyme application and the development of therapeutic compounds.

Latest Patents: Dellweg's latest patents include groundbreaking work on acarviosyl transferase, an enzyme derived from actinomycetes, primarily Actinoplanes sp. SE 50/110 and its mutants. His work details a comprehensive process for isolating, purifying, and characterizing this enzyme, alongside the isolation of the acbD gene responsible for encoding acarviosyl transferase. This technology enhances the conversion of acarbose minor constituents into acarbose and facilitates acarbose purification, leading to advancements in diabetic treatment. Another notable patent focuses on N-alkylated 1,4-dihydropyridinedicarboxylic acid esters, which can be synthesized through various chemical reactions and are proposed to be effective active compounds in the development of cerebral therapeutics.

Career Highlights: Hans-Georg Dellweg has spent key years working with Bayer Aktiengesellschaft, where his research and inventions have propelled the company’s portfolio in pharmaceuticals. His emphasis on biocatalysis not only showcases his innovative mindset but also contributes to Bayer's mission of advancing health through scientific excellence.

Collaborations: Throughout his career, Dellweg has collaborated with distinguished colleagues like Erwin Bischoff and Ulrich E Müller. Their combined expertise and dedication to research have fostered an environment of innovation that has yielded successful patents and transformative technologies in the field.

Conclusion: Hans-Georg Dellweg stands as a testament to the potential of innovation within the scientific community. With several patents that emphasize enzyme applications and therapeutic advancements, his contributions are likely to continue influencing the pharmaceutical landscape for years to come. His work exemplifies the drive toward marrying scientific inquiry with practical applications, ensuring that medicine evolves to meet the needs of patients globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…